▲ BUY
7
/ 10
Conviction
$ Value
$200K
Shares
40,000
Price
$5
Filed
Mar 9
▶ Why this score? (7/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Raha Samraat S.
Title
President and CEO
CIK
0001738340
Roles
Director
Officer
Transaction Details
Transaction Date
2026-03-09
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
493,104
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Raha Samraat S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-14 | MYGN | F | $50K |
| 2026-03-13 | MYGN | F | $169K |
| 2026-03-12 | MYGN | A | $0 |
| 2026-03-09 | MYGN | ▲ | $200K ★ |
| 2025-12-11 | MYGN | F | $216K |
| 2025-05-31 | MYGN | A | $5K |
| 2025-04-30 | MYGN | A | $0 |
Other Insiders at MYGN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Phanstiel S. Louise | $495K | — | 2026-02-27 |
|
Solaiman Shereen
Chief People Officer
|
— | — | 2026-03-14 |
|
Verratti Mark
Chief Operating Officer
|
— | — | 2026-04-14 |
|
Raha Samraat S.
President and CEO
|
— | — | 2026-03-14 |
|
Haas Kevin Richard
Chief Technology Officer
|
— | — | 2026-03-15 |
|
Fox Jennifer Lynne
Chief Legal Officer
|
— | — | 2026-03-13 |
|
Muzzey Dale
Chief Scientific Officer
|
— | — | 2026-04-14 |
|
Donnelly Brian J
Chief Commerical Officer
|
— | — | 2026-03-12 |
|
Wheeler Benjamin Richard
Chief Financial Officer
|
— | — | 2026-03-15 |